Context Therapeutics EPS Diluted from Discontinued Operations (Quarterly) Trends

Context Therapeutics, Inc. (CNTX)

2.48 +0.20 (+8.77%) USD | NASDAQ | Feb 24, 16:00

2.50 +0.02 (+0.81%) After-Hours: 05:57

View EPS Diluted from Discontinued Operations (Quarterly) for CNTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Discontinued Operations (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Discontinued Operations (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Discontinued Operations (Quarterly) Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Imunon, Inc.	--